International Stem Cell Corporation Announces Strong Financial Results for the Quarter Ended March 31, 2022

SAN DIEGO, CA / ACCESSWIRE / May 17, 2022 / International Stem Cell Corporation (OTC PINK:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology

Related Keywords

California ,United States ,Andrey Semechkin ,Russella Kern ,Exchange Commission ,Twitter ,Company Securities ,Facebook ,Lifeline Cell Technology ,International Stem Cell Corporation ,Stem Cell Corporation ,Lifeline Skin Care ,Redeemable Convertible Preferred Stock ,Consolidated Statements ,Months Ended March ,International Stem Cell ,International ,Item ,Fell ,Corporation ,Nnounces ,Strong ,Financial ,Results ,Quarter ,Nded ,Arch ,022 ,